TESSEY C JOSE

Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism WESTON, FL NPI 1285836726

General Payments — all program years on this page

$33,499.74

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 199
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $457.03 across 17 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $457.0317

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Novo Nordisk AS $216.719
Medtronic, Inc. $112.992
Lilly USA, LLC $83.263
BETA BIONICS, INC. $27.632
Xeris Pharmaceuticals, Inc. $16.441

By program year

Program yearAmountRecords
2018 $941.7042
2019 $1,426.7859
2020 $6,619.4611
2021 $7,353.7516
2022 $8,955.0528
2023 $7,745.9726
2024 $457.0317

Records — PY2024 (17)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1087876029 BETA BIONICS, INC. $10.31 05/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087878717 BETA BIONICS, INC. $17.32 06/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096606159 Novo Nordisk Inc $19.79 10/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096607791 Novo Nordisk Inc $22.80 06/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096847633 Novo Nordisk Inc $21.34 04/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096916812 Novo Nordisk Inc $24.83 01/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097042658 Novo Nordisk Inc $23.11 02/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097404424 Novo Nordisk Inc $4.21 11/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097451759 Novo Nordisk Inc $23.13 12/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097579747 Novo Nordisk Inc $27.68 09/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097595655 Novo Nordisk Inc $49.82 01/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117145560 Medtronic, Inc. $16.85 06/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117145562 Medtronic, Inc. $96.14 12/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135456119 Lilly USA, LLC $28.71 05/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135461388 Lilly USA, LLC $26.57 05/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135480991 Lilly USA, LLC $27.98 08/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144615569 Xeris Pharmaceuticals, Inc. $16.44 04/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.